img

Global Cholera Vaccine (Oral Route) Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cholera Vaccine (Oral Route) Market Insights, Forecast to 2034

Global Cholera Vaccine (Oral Route) market is expected to reach to US$ 1087.7 million in 2024, with a positive growth of %, compared with US$ 1027.9 million in 2022. Backed with the increasing demand from downstream industries, Cholera Vaccine (Oral Route) industry is evaluated to reach US$ 1525.6 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Cholera Vaccine (Oral Route) market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Cholera Vaccine (Oral Route) market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


PaxVax
Sanofi
Valneva
EuBiologics
Segment by Type
Shanchol
Dukoral
Vaxchora
Others

Segment by Application


Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Cholera Vaccine (Oral Route) plant distribution, commercial date of Cholera Vaccine (Oral Route), product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Cholera Vaccine (Oral Route) introduction, etc. Cholera Vaccine (Oral Route) Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Cholera Vaccine (Oral Route)
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Cholera Vaccine (Oral Route) Product Introduction
1.2 Market by Type
1.2.1 Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cholera Vaccine (Oral Route) Sales Estimates and Forecasts 2018-2029
2.2 Global Cholera Vaccine (Oral Route) Revenue by Region
2.2.1 Global Cholera Vaccine (Oral Route) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Cholera Vaccine (Oral Route) Revenue by Region (2018-2024)
2.2.3 Global Cholera Vaccine (Oral Route) Revenue by Region (2024-2029)
2.2.4 Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2018-2029)
2.3 Global Cholera Vaccine (Oral Route) Sales Estimates and Forecasts 2018-2029
2.4 Global Cholera Vaccine (Oral Route) Sales by Region
2.4.1 Global Cholera Vaccine (Oral Route) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Cholera Vaccine (Oral Route) Sales by Region (2018-2024)
2.4.3 Global Cholera Vaccine (Oral Route) Sales by Region (2024-2029)
2.4.4 Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Cholera Vaccine (Oral Route) Sales by Manufacturers
3.1.1 Global Cholera Vaccine (Oral Route) Sales by Manufacturers (2018-2024)
3.1.2 Global Cholera Vaccine (Oral Route) Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cholera Vaccine (Oral Route) in 2022
3.2 Global Cholera Vaccine (Oral Route) Revenue by Manufacturers
3.2.1 Global Cholera Vaccine (Oral Route) Revenue by Manufacturers (2018-2024)
3.2.2 Global Cholera Vaccine (Oral Route) Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cholera Vaccine (Oral Route) Revenue in 2022
3.3 Global Key Players of Cholera Vaccine (Oral Route), Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Cholera Vaccine (Oral Route) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cholera Vaccine (Oral Route), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cholera Vaccine (Oral Route), Product Offered and Application
3.8 Global Key Manufacturers of Cholera Vaccine (Oral Route), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cholera Vaccine (Oral Route) Sales by Type
4.1.1 Global Cholera Vaccine (Oral Route) Historical Sales by Type (2018-2024)
4.1.2 Global Cholera Vaccine (Oral Route) Forecasted Sales by Type (2024-2029)
4.1.3 Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2018-2029)
4.2 Global Cholera Vaccine (Oral Route) Revenue by Type
4.2.1 Global Cholera Vaccine (Oral Route) Historical Revenue by Type (2018-2024)
4.2.2 Global Cholera Vaccine (Oral Route) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2018-2029)
4.3 Global Cholera Vaccine (Oral Route) Price by Type
4.3.1 Global Cholera Vaccine (Oral Route) Price by Type (2018-2024)
4.3.2 Global Cholera Vaccine (Oral Route) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Cholera Vaccine (Oral Route) Sales by Application
5.1.1 Global Cholera Vaccine (Oral Route) Historical Sales by Application (2018-2024)
5.1.2 Global Cholera Vaccine (Oral Route) Forecasted Sales by Application (2024-2029)
5.1.3 Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2018-2029)
5.2 Global Cholera Vaccine (Oral Route) Revenue by Application
5.2.1 Global Cholera Vaccine (Oral Route) Historical Revenue by Application (2018-2024)
5.2.2 Global Cholera Vaccine (Oral Route) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2018-2029)
5.3 Global Cholera Vaccine (Oral Route) Price by Application
5.3.1 Global Cholera Vaccine (Oral Route) Price by Application (2018-2024)
5.3.2 Global Cholera Vaccine (Oral Route) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Cholera Vaccine (Oral Route) Market Size by Type
6.1.1 US & Canada Cholera Vaccine (Oral Route) Sales by Type (2018-2029)
6.1.2 US & Canada Cholera Vaccine (Oral Route) Revenue by Type (2018-2029)
6.2 US & Canada Cholera Vaccine (Oral Route) Market Size by Application
6.2.1 US & Canada Cholera Vaccine (Oral Route) Sales by Application (2018-2029)
6.2.2 US & Canada Cholera Vaccine (Oral Route) Revenue by Application (2018-2029)
6.3 US & Canada Cholera Vaccine (Oral Route) Market Size by Country
6.3.1 US & Canada Cholera Vaccine (Oral Route) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Cholera Vaccine (Oral Route) Sales by Country (2018-2029)
6.3.3 US & Canada Cholera Vaccine (Oral Route) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Cholera Vaccine (Oral Route) Market Size by Type
7.1.1 Europe Cholera Vaccine (Oral Route) Sales by Type (2018-2029)
7.1.2 Europe Cholera Vaccine (Oral Route) Revenue by Type (2018-2029)
7.2 Europe Cholera Vaccine (Oral Route) Market Size by Application
7.2.1 Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2029)
7.2.2 Europe Cholera Vaccine (Oral Route) Revenue by Application (2018-2029)
7.3 Europe Cholera Vaccine (Oral Route) Market Size by Country
7.3.1 Europe Cholera Vaccine (Oral Route) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2029)
7.3.3 Europe Cholera Vaccine (Oral Route) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Cholera Vaccine (Oral Route) Market Size
8.1.1 China Cholera Vaccine (Oral Route) Sales (2018-2029)
8.1.2 China Cholera Vaccine (Oral Route) Revenue (2018-2029)
8.2 China Cholera Vaccine (Oral Route) Market Size by Application
8.2.1 China Cholera Vaccine (Oral Route) Sales by Application (2018-2029)
8.2.2 China Cholera Vaccine (Oral Route) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cholera Vaccine (Oral Route) Market Size by Type
9.1.1 Asia Cholera Vaccine (Oral Route) Sales by Type (2018-2029)
9.1.2 Asia Cholera Vaccine (Oral Route) Revenue by Type (2018-2029)
9.2 Asia Cholera Vaccine (Oral Route) Market Size by Application
9.2.1 Asia Cholera Vaccine (Oral Route) Sales by Application (2018-2029)
9.2.2 Asia Cholera Vaccine (Oral Route) Revenue by Application (2018-2029)
9.3 Asia Cholera Vaccine (Oral Route) Sales by Region
9.3.1 Asia Cholera Vaccine (Oral Route) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Cholera Vaccine (Oral Route) Revenue by Region (2018-2029)
9.3.3 Asia Cholera Vaccine (Oral Route) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Market Size by Type
10.1.1 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Market Size by Application
10.2.1 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Country
10.3.1 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 PaxVax
11.1.1 PaxVax Company Information
11.1.2 PaxVax Overview
11.1.3 PaxVax Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 PaxVax Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 PaxVax Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sanofi Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Valneva
11.3.1 Valneva Company Information
11.3.2 Valneva Overview
11.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Valneva Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Valneva Recent Developments
11.4 EuBiologics
11.4.1 EuBiologics Company Information
11.4.2 EuBiologics Overview
11.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 EuBiologics Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 EuBiologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cholera Vaccine (Oral Route) Industry Chain Analysis
12.2 Cholera Vaccine (Oral Route) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cholera Vaccine (Oral Route) Production Mode & Process
12.4 Cholera Vaccine (Oral Route) Sales and Marketing
12.4.1 Cholera Vaccine (Oral Route) Sales Channels
12.4.2 Cholera Vaccine (Oral Route) Distributors
12.5 Cholera Vaccine (Oral Route) Customers
13 Market Dynamics
13.1 Cholera Vaccine (Oral Route) Industry Trends
13.2 Cholera Vaccine (Oral Route) Market Drivers
13.3 Cholera Vaccine (Oral Route) Market Challenges
13.4 Cholera Vaccine (Oral Route) Market Restraints
14 Key Findings in The Global Cholera Vaccine (Oral Route) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Shanchol
Table 3. Major Manufacturers of Dukoral
Table 4. Major Manufacturers of Vaxchora
Table 5. Major Manufacturers of Others
Table 6. Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Cholera Vaccine (Oral Route) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Cholera Vaccine (Oral Route) Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Cholera Vaccine (Oral Route) Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2018-2024)
Table 11. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2024-2029)
Table 12. Global Cholera Vaccine (Oral Route) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Cholera Vaccine (Oral Route) Sales by Region (2018-2024) & (K Units)
Table 14. Global Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (K Units)
Table 15. Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2018-2024)
Table 16. Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2024-2029)
Table 17. Global Cholera Vaccine (Oral Route) Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Cholera Vaccine (Oral Route) Sales Share by Manufacturers (2018-2024)
Table 19. Global Cholera Vaccine (Oral Route) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Cholera Vaccine (Oral Route) Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Cholera Vaccine (Oral Route), Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Cholera Vaccine (Oral Route) Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Cholera Vaccine (Oral Route) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Cholera Vaccine (Oral Route) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccine (Oral Route) as of 2022)
Table 25. Global Key Manufacturers of Cholera Vaccine (Oral Route), Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Cholera Vaccine (Oral Route), Product Offered and Application
Table 27. Global Key Manufacturers of Cholera Vaccine (Oral Route), Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 30. Global Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
Table 31. Global Cholera Vaccine (Oral Route) Sales Share by Type (2018-2024)
Table 32. Global Cholera Vaccine (Oral Route) Sales Share by Type (2024-2029)
Table 33. Global Cholera Vaccine (Oral Route) Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Cholera Vaccine (Oral Route) Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Cholera Vaccine (Oral Route) Revenue Share by Type (2018-2024)
Table 36. Global Cholera Vaccine (Oral Route) Revenue Share by Type (2024-2029)
Table 37. Cholera Vaccine (Oral Route) Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Cholera Vaccine (Oral Route) Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (K Units)
Table 40. Global Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
Table 41. Global Cholera Vaccine (Oral Route) Sales Share by Application (2018-2024)
Table 42. Global Cholera Vaccine (Oral Route) Sales Share by Application (2024-2029)
Table 43. Global Cholera Vaccine (Oral Route) Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Cholera Vaccine (Oral Route) Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Cholera Vaccine (Oral Route) Revenue Share by Application (2018-2024)
Table 46. Global Cholera Vaccine (Oral Route) Revenue Share by Application (2024-2029)
Table 47. Cholera Vaccine (Oral Route) Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Cholera Vaccine (Oral Route) Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Cholera Vaccine (Oral Route) Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Cholera Vaccine (Oral Route) Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Cholera Vaccine (Oral Route) Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Cholera Vaccine (Oral Route) Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Cholera Vaccine (Oral Route) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Cholera Vaccine (Oral Route) Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Cholera Vaccine (Oral Route) Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
Table 62. Europe Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 63. Europe Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
Table 64. Europe Cholera Vaccine (Oral Route) Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Cholera Vaccine (Oral Route) Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (K Units)
Table 67. Europe Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
Table 68. Europe Cholera Vaccine (Oral Route) Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Cholera Vaccine (Oral Route) Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Cholera Vaccine (Oral Route) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Cholera Vaccine (Oral Route) Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Cholera Vaccine (Oral Route) Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (K Units)
Table 74. Europe Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
Table 75. China Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 76. China Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
Table 77. China Cholera Vaccine (Oral Route) Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Cholera Vaccine (Oral Route) Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (K Units)
Table 80. China Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
Table 81. China Cholera Vaccine (Oral Route) Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Cholera Vaccine (Oral Route) Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 84. Asia Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
Table 85. Asia Cholera Vaccine (Oral Route) Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Cholera Vaccine (Oral Route) Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (K Units)
Table 88. Asia Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
Table 89. Asia Cholera Vaccine (Oral Route) Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Cholera Vaccine (Oral Route) Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Cholera Vaccine (Oral Route) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Cholera Vaccine (Oral Route) Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Cholera Vaccine (Oral Route) Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Cholera Vaccine (Oral Route) Sales by Region (2018-2024) & (K Units)
Table 95. Asia Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
Table 109. PaxVax Company Information
Table 110. PaxVax Description and Major Businesses
Table 111. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. PaxVax Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. PaxVax Recent Developments
Table 114. Sanofi Company Information
Table 115. Sanofi Description and Major Businesses
Table 116. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sanofi Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Sanofi Recent Developments
Table 119. Valneva Company Information
Table 120. Valneva Description and Major Businesses
Table 121. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Valneva Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Valneva Recent Developments
Table 124. EuBiologics Company Information
Table 125. EuBiologics Description and Major Businesses
Table 126. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. EuBiologics Cholera Vaccine (Oral Route) Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. EuBiologics Recent Developments
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Cholera Vaccine (Oral Route) Distributors List
Table 132. Cholera Vaccine (Oral Route) Customers List
Table 133. Cholera Vaccine (Oral Route) Market Trends
Table 134. Cholera Vaccine (Oral Route) Market Drivers
Table 135. Cholera Vaccine (Oral Route) Market Challenges
Table 136. Cholera Vaccine (Oral Route) Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholera Vaccine (Oral Route) Product Picture
Figure 2. Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Cholera Vaccine (Oral Route) Market Share by Type in 2022 & 2029
Figure 4. Shanchol Product Picture
Figure 5. Dukoral Product Picture
Figure 6. Vaxchora Product Picture
Figure 7. Others Product Picture
Figure 8. Global Cholera Vaccine (Oral Route) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Cholera Vaccine (Oral Route) Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Research & Academic Laboratories
Figure 12. Pharmaceutical & Biotechnology Companies
Figure 13. Others
Figure 14. Cholera Vaccine (Oral Route) Report Years Considered
Figure 15. Global Cholera Vaccine (Oral Route) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Cholera Vaccine (Oral Route) Revenue 2018-2029 (US$ Million)
Figure 17. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Cholera Vaccine (Oral Route) Revenue Market Share by Region (2018-2029)
Figure 19. Global Cholera Vaccine (Oral Route) Sales 2018-2029 ((K Units)
Figure 20. Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Cholera Vaccine (Oral Route) Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Cholera Vaccine (Oral Route) Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Cholera Vaccine (Oral Route) Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Cholera Vaccine (Oral Route) Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Cholera Vaccine (Oral Route) Sales YoY (2018-2029) & (K Units)
Figure 26. China Cholera Vaccine (Oral Route) Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Cholera Vaccine (Oral Route) Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Cholera Vaccine (Oral Route) Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Cholera Vaccine (Oral Route) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Cholera Vaccine (Oral Route) in the World: Market Share by Cholera Vaccine (Oral Route) Revenue in 2022
Figure 33. Global Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2018-2029)
Figure 35. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2018-2029)
Figure 36. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2018-2029)
Figure 37. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Cholera Vaccine (Oral Route) Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Cholera Vaccine (Oral Route) Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Cholera Vaccine (Oral Route) Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Cholera Vaccine (Oral Route) Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Cholera Vaccine (Oral Route) Revenue Share by Country (2018-2029)
Figure 43. US & Canada Cholera Vaccine (Oral Route) Sales Share by Country (2018-2029)
Figure 44. U.S. Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Cholera Vaccine (Oral Route) Sales Market Share by Type (2018-2029)
Figure 47. Europe Cholera Vaccine (Oral Route) Revenue Market Share by Type (2018-2029)
Figure 48. Europe Cholera Vaccine (Oral Route) Sales Market Share by Application (2018-2029)
Figure 49. Europe Cholera Vaccine (Oral Route) Revenue Market Share by Application (2018-2029)
Figure 50. Europe Cholera Vaccine (Oral Route) Revenue Share by Country (2018-2029)
Figure 51. Europe Cholera Vaccine (Oral Route) Sales Share by Country (2018-2029)
Figure 52. Germany Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 53. France Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 57. China Cholera Vaccine (Oral Route) Sales Market Share by Type (2018-2029)
Figure 58. China Cholera Vaccine (Oral Route) Revenue Market Share by Type (2018-2029)
Figure 59. China Cholera Vaccine (Oral Route) Sales Market Share by Application (2018-2029)
Figure 60. China Cholera Vaccine (Oral Route) Revenue Market Share by Application (2018-2029)
Figure 61. Asia Cholera Vaccine (Oral Route) Sales Market Share by Type (2018-2029)
Figure 62. Asia Cholera Vaccine (Oral Route) Revenue Market Share by Type (2018-2029)
Figure 63. Asia Cholera Vaccine (Oral Route) Sales Market Share by Application (2018-2029)
Figure 64. Asia Cholera Vaccine (Oral Route) Revenue Market Share by Application (2018-2029)
Figure 65. Asia Cholera Vaccine (Oral Route) Revenue Share by Region (2018-2029)
Figure 66. Asia Cholera Vaccine (Oral Route) Sales Share by Region (2018-2029)
Figure 67. Japan Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 71. India Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Cholera Vaccine (Oral Route) Sales Share by Country (2018-2029)
Figure 78. Brazil Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Cholera Vaccine (Oral Route) Revenue (2018-2029) & (US$ Million)
Figure 83. Cholera Vaccine (Oral Route) Value Chain
Figure 84. Cholera Vaccine (Oral Route) Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries